About 6.5% of FDA-era trial participants developed hypothyroidism, which is why thyroid checks were built into the original prescribing pattern
Despite its short duration, the current study had significant results in its composite endpoint, but did not significantly impact the physical activity (6-min walk test), QoL, and mTOR phosphorylation which may have improved with prolonged supplementation
The retatrutide dose schedule follows yet another escalation pattern, and comparing it to tirzepatide or semaglutide requires the same caution about non-equivalent milligrams
Additionally, there is no approved oral formulation to compound from
In contrast, non-responders more frequently display dysbiotic profiles enriched in taxa linked to insulin resistance and inflammatory metabolism, such as P